Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From November 08, 2017 to November 10, 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzyldimethyl(octadecyl)ammonium chloride
EC Number:
204-527-9
EC Name:
Benzyldimethyl(octadecyl)ammonium chloride
Cas Number:
122-19-0
Molecular formula:
C27H50N.Cl
IUPAC Name:
.
Test material form:
solid
Specific details on test material used for the study:
Identity: Benzyldimethyl(octadecyl)ammonium chloride
Batch no: 15817
Composition: 100%
Cationic activity: 96.2%
Appearance: White solid
Dilution: Not diluted
Expiry date: 09/2019
Storage conditions: Room temperature, protect from humidity and water

In vitro test system

Test system:
other: SkinEthic Reconstructed Human Epidermis
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
other: Not specified
Justification for test system used:
The SkinEthicTM skin irritation test method is a validated alternative test procedure to the Draize Rabbit Skin irritation Test and endorsed by OECD Guideline 439.
Vehicle:
unchanged (no vehicle)
Details on test system:
SkinEthicTM Reconstructed Human Epidermis:

SkinEthicTM Reconstructed Human Epidermis is a three dimensional reconstructed human skin model comprising freshly isolated normal epidermal keratinocytes (NHEK: the major cellular component of skin), which are cultured at the air liquid interface on specialised culture inserts to develop a stratified differentiated epidermis characteristic of skin in vivo. The model consist of multiple layers of viable epithelial cells and a functional multi-layered stratum corneum with robust barrier function.

The SkinEthic skin irritation assay predicts and classifies the skin irritation potential of a chemical by assessment of its cytotoxic effect following its topical application directly to the skin surface and its subsequent penetration through the stratum corneum
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
16±2 mg
Duration of treatment / exposure:
42 ± 1 minutes
Duration of post-treatment incubation (if applicable):
42 ± 1 h
Number of replicates:
3

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
42 minutes exposure
Value:
96.1
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation

Applicant's summary and conclusion

Interpretation of results:
other: CLP criteria not met
Remarks:
(not irritating)
Conclusions:
Under study conditions, the test substance was determined to be non-irritant to skin
Executive summary:

An in vitro study was conducted to determine the skin irritation potential of the test substance, C18 ADBAC (active: 96.2%), using Reconstructed Human Epidermis (RHE) Test Method, according to OECD Test Guideline 439, in compliance with GLP. On Day 18, SkinEhticTM tissues were pre-incubated overnight in the growth culture medium. The tissues were then placed in maintenance culture medium prior to application of the test substance. 10 µL distilled water followed by 16±2 mg of powder was applied to each of the 3 RHE tissue for 42±1 minutes, then rinsed and further incubated, post exposure, for 42±1 h at 37˚C, 5% CO2±1% and 95% humidified atmosphere. Cell viability was quantitatively measured (based on dehydrogenase conversion of the MTT dye (Methylthiazolyldiphenyl-tetrazolium bromide into a blue formazan salt) by determining the absorbance at 570 nm. Sterile Dulbecco’s Phosphate Buffered Saline (DPBS) and sodium dodecyl sulphate (5% in water) were used as negative and positive controls respectively. A test substance is considered to be an irritant to skin if the skin model viability after exposure and post-treatment incubation is ≤50%. The final percentage of viability obtained with the test substance was 96.1%, which was well above the 50% irritant threshold. Optical Density (OD) results obtained with negative and positive controls were within the acceptance limits; hence the study met all the acceptance/validity criteria. Under study conditions, the test substance was determined to be non-irritant to skin (Catoire, 2017).